|
Characteristics of human herpesviruses, Chlamydiae and parvovirus |
|||||
| Organism |
Receptors |
Main cellular tropism |
Proposed latency cell |
Other tropism |
References |
|
|
|||||
| EBV |
CD21, MHC-II, α5β1 integrin |
B |
B |
EPC, EC |
[8] |
| CMV |
EGFR |
M/M |
M/M; EC |
N, EPC, EC |
[174] |
| HHV6 |
CD46+ |
M/M, T, B |
M/M |
N, EPC |
[175] |
| HHV7 |
CD4+ heparan sulfate receptor |
T |
M/M |
N, EPC, EC |
[176,177] |
| HHV8 |
Heparan sulfate receptor, EGFR |
EC, M/M, B, T |
B |
N, EPC |
[174,178] |
| Chlamydia pneumoniae |
Heparan sulfate receptor |
M/M |
EC, EPC |
[179] |
|
| Chlamydia trachomatis |
M/M |
EC, EPC |
|||
| Parvovirus B19 |
Erythrocyte P antigen |
Erythroid precursors |
EC |
[66,67] |
|
|
B, B cells; CMV, cytomegalovirus; EBV, Epstein–Barr virus; EC, endothelial cells; EGFR, epidermal growth factor receptor; EPC, epithelial cells; HHV, human herpesvirus; MHC, major histocompatibility complex; M/M, myelomonocytic cells; N, neural cells; T, T cells. | |||||
Posnett and Yarilin Arthritis Research & Therapy 2005 7:74 doi:10.1186/ar1691 |
|||||